Skip to content
Search

Latest Stories

RPS launches largest edition of Medicines, Ethics and Practice

RPS launches largest edition of Medicines, Ethics and Practice

The MEP now incorporates guidance from the new RPS Patient Safety Professional standards

The Royal Pharmaceutical Society (RPS) has launched its latest edition of Medicines, Ethics and Practice (MEP), marking it as the largest ever at 258 pages—reflecting a substantial 30 per cent increase in content from the previous edition.

Key updates in this year’s edition include expanded prescribing content, new patient safety standards, a joint position statement by RPS and RCN, and updated information on Valproate Pregnancy Prevention Programme (PPP).


Rakhee Amin, MEP Editor, said: “The MEP continues to support our members and the wider pharmacy profession. The additions of prescribing and patient safety reflect our ongoing commitment to high standards of professional practice.

“We thank everyone who helped build this edition of the MEP, and those who provided expert advice and information during its preparation.”

The MEP now includes detailed signposting to RPS resources and the full text of RPS competency frameworks and guidance, such as the Competency Framework for All Prescribers, the Competency Framework for Designated Prescribing Practitioners, and the Professional Guidance on Expanding Prescribing Scope of Practice.

The latest edition also incorporates guidance from the new RPS Patient Safety Professional standards, designed to support pharmacists in reporting adverse effects and handling dispensing errors more effectively.

These standards have been developed by the RPS, Association of Pharmacy Technicians UK and Pharmacy Forum NI, with the support of an expert steering group and public consultation.

In collaboration with the Royal College of Nursing (RCN), the RPS has added updated information and guidance on the safe practice of prescribing, dispensing, supply, and administration by the same individual.

Additionally, the 47 edition includes updated information on the valproate pregnancy prevention programme, incorporating new legislation and the most recent MHRA guidance on full pack dispensing of valproate-containing medicines.

All Foundation Trainee Members of the RPS will receive a copy of the new MEP free of charge as part of their membership. Copies are available for £52.50 for members and £70 for non-members.

Additionally, all currently practising GB-based pharmacists (excluding Student, Retired, or International Members) can request a free physical copy by completing a quick 4-question form available in the Printed Materials Opt-In section on www.rpharms.com/myRPS.

All RPS members, regardless of their membership type, can access the digital MEP.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less